How Does Cancer Happen? A Plain-Language Guide to Cell Growth Gone Wrong
2026-09-14 · 7 min read

Cancer begins when cells stop following the rules that keep tissue healthy. Here is what goes wrong, why it takes time, and what the process means for prevention.
Medically reviewed by the Bangkok Stem Cell Center medical team
Most people hear the word cancer and picture a single event: a cell turns bad and starts multiplying out of control. In reality, cancer is usually the end result of a long sequence of failures. Cells accumulate mistakes, ignore stop signals, and eventually escape the systems that would normally remove them. Understanding that sequence makes the disease less mysterious and explains why prevention and early detection matter so much.
Cells are supposed to follow a contract
Every cell in your body carries a kind of employment contract. It is allowed to divide when the body needs new cells, and it is expected to stop when enough have been made. If it becomes damaged beyond repair, it is supposed to self-destruct through a process called apoptosis. These rules are enforced by genes: some genes push division forward, like accelerators, and others apply the brakes or call for destruction.
A healthy cell obeys both sets of signals. A cancer cell has lost that balance. It presses the accelerator, ignores the brakes, and refuses to die when it should.
The two-hit idea: accelerators stick, brakes fail
One of the most useful frameworks in cancer biology is that a cell usually needs more than one critical mistake before it becomes dangerous. An accelerator gene, called an oncogene, might get stuck in the on position. A brake gene, called a tumour suppressor, might stop working. DNA repair genes, which normally fix copying errors, might also fail.
A single mutation rarely causes cancer by itself. The risk rises when several of these systems fail in the same cell lineage, which is why most cancers become more common with age. The longer cells have been dividing, the more chances they have had to accumulate errors.
Where mutations come from
Some mutations are inherited. Genes such as BRCA1 and BRCA2 are famous examples: people born with a faulty copy have a higher lifetime risk of breast, ovarian and certain other cancers because one brake is already missing. But inherited mutations account for only a minority of cancers.
Most mutations are acquired over a lifetime. They can come from copying mistakes during normal cell division, from ultraviolet radiation damaging skin cell DNA, from tobacco chemicals mutating lung cells, from alcohol metabolites irritating the digestive tract, or from chronic inflammation keeping cells in a state of constant repair. Age remains the single biggest risk factor because it simply allows more time for these events to stack up.
Why the immune system does not catch every cancer
The immune system does recognise and kill many early abnormal cells. Natural killer cells, T cells and other immune components patrol tissues looking for signs of stress or mutation. This immune surveillance probably prevents countless cancers that never become clinically visible.
But surveillance is not perfect. Some cancer cells reduce the flags that immune cells look for. Others release signals that exhaust or confuse immune attackers. Some tumours build a physical and chemical barrier around themselves that keeps immune cells out. When a cancer becomes clinically detectable, it has usually found at least one way to hide or defend itself.
Inflammation is a double-edged sword
Inflammation is the body's repair response. It brings immune cells, growth factors and nutrients to damaged tissue. When it resolves quickly, it is protective. When it drags on for years, it creates an environment where cells divide repeatedly and where DNA-damaging molecules accumulate.
That is why chronic infections, autoimmune disease, obesity and long-term irritants are linked to cancer risk. They keep tissues in a state of low-grade inflammation that provides the background noise in which mutations can become fixed.
Why cancer behaves differently in different organs
A mutation in one organ does not produce the same disease as the same mutation in another. The behaviour of a cancer depends on the tissue it starts in, the blood supply available, the local immune environment, and the particular combination of mutations it carries. That is why cancer treatment is so specific to type and subtype, and why a drug that works brilliantly for one cancer may do nothing for another.
This organ-specific behaviour also explains why screening tests differ. Mammography, colonoscopy, cervical cytology, low-dose CT for lung cancer and PSA discussion all target the natural history of cancer in specific tissues.
Prevention is about stacking the odds
No lifestyle choice guarantees immunity from cancer, and no screening test prevents every death. But the same things that reduce mutation load and chronic inflammation do shift the odds: not smoking, limiting alcohol, maintaining a healthy weight, staying physically active, protecting skin from excessive ultraviolet exposure, and keeping up with age-appropriate screening.
Vaccines that prevent cancer-causing infections, such as HPV and hepatitis B, remove a major source of chronic inflammation and viral DNA damage. These are among the most effective cancer prevention tools available.
The honest bottom line
Cancer is not one disease, and it is rarely caused by a single mistake. It is the result of cells gradually losing the genetic and immune controls that keep them orderly. That gradual nature is frightening because it means risk accumulates silently, but it is also hopeful because it means there are many points along the way where the process can be slowed or caught early.
If you are worried about personal risk because of family history, symptoms, or lifestyle factors, the right next step is a conversation with a physician who can assess your individual risk and recommend appropriate screening. General information is useful, but personal medical decisions need personal medical advice.
Reviewed by Bangkok Stem Cell Center Medical Team | Last updated: October 2026
Travelling to Bangkok During Cancer Treatment: A Medical Planning Checklist
Travel during cancer treatment requires more than a flight and hotel. This checklist helps patients coordinate records, medicines, safety and follow-up before leaving home.
Considering Cancer Immunotherapy in Bangkok? Questions to Ask Before You Travel
The word immunotherapy covers very different treatments. Before travelling, establish exactly what is proposed, why it fits the diagnosis, and who will manage complications.

